OptiLIGHT with Lumenis patented Optimal Pulse Technology uses precise, intense broad spectrum light to address the inflammation - on the key underlining factors in dry eye disease due to MGD.
THE FIRST AND ONLY
LIGHT-THERAPY, FDA-APPROVED
FOR DRY EYE MANAGEMENT


OptiLIGHT is specifically developed to reach the delicate contours of the treated area safely, effectively and gently. OptiLIGHT sets new treatment standards and helps patients find a real solution for their dry eyes.
6.3x more expressible glands
2.7x improvement in tear break up time
Backed by numerous clinical studies, OptiLIGHT’s novel Optimal Pulse Technology (OPT®) provides a transformative, safe, and efficacious way to improve signs of Dry Eye disease due to MGD.
OptiLIGHT was designed for your peace of mind, delivering treatment that is safe and precise.
A course of treatment typically includes 3 sessions spaced 2–4 weeks apart.
Each session usually takes only 10–15 minutes.
During the treatment your practitioner will apply a coupling gel on the treatment area and cover your eyes with shields.
You may experience a warm sensation as light is applied to the skin, the treatment is gentle with minimum discomfort.
OptiLIGHT is often followed by Meibomian Glands expression.


GENTLE, FAST, NO-DOWNTIME
Immediately following treatment, you may experience some redness. This will usually disappear within a few hours. You can return to your daily activities and apply makeup straight away in most cases.
You will be advised to stay out of direct sunlight for a few days and to apply sunscreen. Patients usually report an improvement after their 2nd or 3rd treatment.
Maintenance treatments are usually recommended every 6–12 months, to ensure the best long-term results.
Before
After